Company intelligence / Profile preview

Baxter BioPharma Solutions

Bloomington, Indiana, United States

Ownership: Private
Development stage: Other

Overview

Baxter BioPharma Solutions (now Simtra BioPharma Solutions post-2023 acquisition) is a leading global contract manufacturer for sterile injectables, supporting clinical and commercial production for diverse pharmaceutical clients, including recent sterile fill-finish for major COVID-19 vaccines; it is recognized for high operational excellence and regulatory compliance.[3][5][10]

Modalities: Small moleculeBiologicVaccineAntibody-drug conjugateCytotoxic compoundHighly potent compound
Industry: Contract Manufacturing Organization

Partnerships

Moderna (sterile fill-finish for COVID-19 mRNA vaccine)BioNTech (sterile fill-finish for COVID-19 mRNA vaccine)

Beyond the preview

Go deeper on Baxter BioPharma Solutions.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Baxter BioPharma Solutions.

Explore the full profile